Neoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB Non-Small Cell Lung Cancer
Clinical trial NCT04326153 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04326153
- Sponsor
- The First Hospital of Jilin University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-20
- Primary completion
- 2023-09-06
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.